Difficulty: Medium
Average Score: 90%
Practice
Indicate the beta receptor antagonist, which has the longest duration of action:
Correct answer
C
Rationale
In this question, the correct answer is C) Nadolol. Nadolol is a beta receptor antagonist that has the longest duration of action among the options provided. It is a non-selective beta blocker with a half-life of approximately 20-24 hours, leading to its sustained pharmacological effects.
Propranolol (Option A) is a non-selective beta blocker with a shorter duration of action compared to Nadolol. Metoprolol (Option B) is a selective beta-1 receptor antagonist with a shorter half-life than Nadolol. Timolol (Option D) is a non-selective beta blocker used primarily for ophthalmic conditions and has a shorter duration of action compared to Nadolol.
Understanding the duration of action of pharmacological treatments is crucial in clinical practice, especially when considering dosing frequency and treatment adherence. Nadolol's long duration of action allows for once-daily dosing, which can improve patient compliance and therapeutic outcomes.
Educationally, this question highlights the importance of pharmacokinetics in selecting appropriate medications for patients. It emphasizes the need for healthcare providers to have a thorough understanding of drug characteristics to make informed decisions regarding treatment options based on individual patient needs.
Propranolol (Option A) is a non-selective beta blocker with a shorter duration of action compared to Nadolol. Metoprolol (Option B) is a selective beta-1 receptor antagonist with a shorter half-life than Nadolol. Timolol (Option D) is a non-selective beta blocker used primarily for ophthalmic conditions and has a shorter duration of action compared to Nadolol.
Understanding the duration of action of pharmacological treatments is crucial in clinical practice, especially when considering dosing frequency and treatment adherence. Nadolol's long duration of action allows for once-daily dosing, which can improve patient compliance and therapeutic outcomes.
Educationally, this question highlights the importance of pharmacokinetics in selecting appropriate medications for patients. It emphasizes the need for healthcare providers to have a thorough understanding of drug characteristics to make informed decisions regarding treatment options based on individual patient needs.